Researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without problematic side effects.

Incidences for many common types of cancer have risen in recent years, with young women experiencing the brunt of the shift.

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or metastatic hormone receptor HR+, HER2- breast cancer in adult patients who have previously received endocrine-based therapy and chemotherapy for unresectable or metastatic disease, according to a news release.

Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her announcement in August that she was diagnosed with DCIS, which stands for ductal carcinoma in situ and is a form of breast cancer.

The Breast Cancer Risk Assessment Tool (BCRAT), also known as The Gail Model, is a tool used by healthcare professionals to estimate a woman's risk of developing invasive breast cancer within the next five years and within her lifetime (up to age 90), according to the National Cancer Institute.

Breast Cancer Now said the treatment, which is also known as Lynparza, will be an “valuable alternative” for patients. The National Institute for Health and Care Excellence (Nice) said the drug can be used for “treating HER2-negative locally advanced ...

Adjuvant chest wall irradiation should be omitted in most patients meeting the eligibility criteria for SUPREMO,” said Ian Kunkler, MB BChir.

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by the American Cancer Society.

After getting a metastatic breast cancer diagnosis, you may experience anxiety and depression. Here are some ways to manage and when to speak with a healthcare provider.

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and testing for inherited genetic mutations linked with increased cancer risk.